ストックスクリーナーアプリを入手
1.98
4.81%
-0.10
前日終値:
$2.08
開ける：
$2.12
24時間の取引高:
451.85K
Relative Volume:
0.80
時価総額：
$85.04M
収益：
$88.55M
当期純損益:
$-53.21M
株価収益率:
-1.5303
EPS:
-1.2939
ネットキャッシュフロー:
$-29.48M
1週間 パフォーマンス:
-13.16%
1か月 パフォーマンス:
-2.94%
6か月 パフォーマンス:
+8.79%
1年 パフォーマンス:
+17.16%
1日の値動き範囲:
$1.98
$2.16
1週間の範囲:
$1.98
$2.33
52週間の値動き範囲:
$1.13
$2.89
Pulmonx Corp Stock (LUNG) Company Profile
Compare LUNG vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
1.98 | 89.33M | 88.55M | -53.21M | -29.48M | -1.2939 |
ABT
Abbott Laboratories
|
105.23 | 182.59B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.89 | 118.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.39 | 106.03B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.96 | 65.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.18 | 49.99B | 6.30B | 1.07B | 1.09B | 1.8406 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-31 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-03-10 | 開始されました | D. Boral Capital | Buy |
| 2024-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-06-04 | 開始されました | Lake Street | Buy |
| 2024-02-23 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-09-05 | 開始されました | Craig Hallum | Buy |
| 2023-02-27 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-12-12 | アップグレード | Citigroup | Neutral → Buy |
| 2022-07-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2021-12-08 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-04-01 | 開始されました | Citigroup | Buy |
| 2021-03-25 | 開始されました | Piper Sandler | Neutral |
| 2021-03-10 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-01-04 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-10-26 | 開始されました | BofA Securities | Buy |
| 2020-10-26 | 開始されました | Canaccord Genuity | Buy |
| 2020-10-26 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-10-26 | 開始されました | Stifel | Buy |
| 2020-10-26 | 開始されました | Wells Fargo | Equal Weight |
すべてを表示
Pulmonx Corp (LUNG) 最新ニュース
Pulmonx Corp Officer Radhakrishnan Srikanth Sells 14,245 Shares at $2.26 Each (NASDAQ: LUNG) - Kalkine Media
Pulmonx general counsel David Lehman sells $32,393 in stock By Investing.com - Investing.com South Africa
Pulmonx CEO French Glendon E. III Disposes of 41,882 Shares at $2.26 Each - Kalkine Media
Pulmonx CCO Geoffrey Rose sells $17,804 in lung shares By Investing.com - Investing.com South Africa
Pulmonx chief science officer sells $32,192 in stock By Investing.com - Investing.com Australia
Pulmonx CCO Geoffrey Rose sells $17,804 in lung shares - Investing.com
Pulmonx general counsel David Lehman sells $32,393 in stock - Investing.com
Pulmonx chief science officer sells $32,192 in stock - Investing.com
Insider at Pulmonx (LUNG) sells shares to cover taxes - Stock Titan
Pulmonx (LUNG) exec sells shares to cover RSU taxes - Stock Titan
Pulmonx (LUNG) general counsel sells shares to cover RSU taxes - Stock Titan
Pulmonx Shares Fall Following Recent Gains - finance.yahoo.com
Why is Pulmonx stock sliding today? - Investing.com
Why is Pulmonx stock sliding today? By Investing.com - Investing.com Australia
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - finance.yahoo.com
Pulmonx will take investor meetings in Boston and New York Sept. 9-10 - Stock Titan
Pulmonx to Participate in Upcoming Investor Conferences - finance.yahoo.com
Pulmonx Corp (NASDAQ: LUNG) Share Price, LUNG Stock News, LUNG Share Price & Updates - Kalkine
Pulmonx Rebuilds Sales Force, Targets Growth and AeriSeal Launch Next Year - MarketBeat
What Makes Pulmonx Corporation (LUNG) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Morgan Stanley (LUNG) reports 6.9% Pulmonx stake in updated ownership filing - Stock Titan
Pulmonx at Canaccord Genuity growth conference: turnaround gains pace - Investing.com
Pulmonx (LUNG) Q2 2026 Earnings Call Transcript - The Globe and Mail
Pulmonx Corp 2026: Revenue $22.76M, EPS ($0.24) — 10-Q Summary - TradingView
Pulmonx (LUNG) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Earnings Release: Here's Why Analysts Cut Their Pulmonx Corporation (NASDAQ:LUNG) Price Target To US$3.40 - Sahm
LUNG Looks 82.5% Undervalued on GF Value™ Despite Financial Chal - GuruFocus
Pulmonx Target of Unusually Large Options Trading (NASDAQ:LUNG) - MarketBeat
Earnings call transcript: Pulmonx tops Q2 2026 estimates, shares jump 14.4% - Investing.com
Pulmonx Q2 Revenue Falls 5 Percent To $22.8 Million - Quiver Quantitative
Pulmonx's Aug. 11 Boston fireside chat will be webcast live - Stock Titan
LUNG|Pulmonx Corp|Price:1.225|Chg%:+0.055 - TradingKey
Pulmonx Corp (LUNG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pulmonx Corp expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Pulmonx Reports Q1 2026 Earnings with Strategic Outlook - Intellectia AI
Pulmonx Market Sentiment - Benzinga España
Pulmonx Corp. Revenue Breakdown – MUN:4NI - TradingView
Pulmonx Corp (LUNG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Pulmonx Corp (LUNG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Pulmonx Corp (LUNG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Pulmonx Corp (LUNG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Pulmonx Corp (LUNG) Cash Flow - TradingKey
TradingKey - TradingKey
LUNG|Pulmonx Corp|Price:2.305|Chg%:+0.265 - TradingKey
Pulmonx (LUNG) Projected to Release Earnings on Wednesday - MarketBeat
Pulmonx Sets July 29 Webcast to Discuss Second-Quarter Results - Stock Titan
Pulmonx Corp (LUNG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Pulmonx (NASDAQ:LUNG) Sparks Fresh Penny Stock Buzz - Kalkine Media
Pulmonx Corp highlights lung device strategy as a specialized medtech player - ad-hoc-news.de
Price to sales forward of Pulmonx Corporation – NASDAQ:LUNG - TradingView
Enterprise value to EBIT forward of Pulmonx Corporation – NASDAQ:LUNG - TradingView
Pulmonx Corp (LUNG) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
1.53%
大文字化:
|
ボリューム (24 時間):